CPAP therapy remains the gold standard for treating obstructive sleep apnea (OSA). Prescribing it is straightforward. Getting patients to use it consistently, night after night, month after month, is an entirely different problem.
Most clinicians already know this. Non-adherence rates have remained stubbornly high for decades, even as devices have become quieter, smaller, and more comfortable. The 90-day compliance window required by payers creates urgency, but it doesn’t account for the behavioral realities of habit formation, the impact of early negative experiences, or the social determinants that shape whether someone actually uses their equipment.
The gap between “device delivered” and “therapy established” is where outcomes fall apart.
Rotech Healthcare’s SleepWELL™ Program was designed to close that gap — functioning as an extension of clinical care teams with structured monitoring, proactive outreach, and the kind of early-phase support that research consistently links to improved long-term adherence.
The Adherence Problem Isn’t About Devices Anymore
If better equipment solved the adherence problem, we’d have solved it by now. Modern CPAP machines are dramatically improved from a decade ago, with auto-adjusting pressures, integrated humidification, quieter motors, and sleeker profiles. Yet adherence rates have barely budged.
The issue is behavioral, not mechanical.
Clinicians are asking patients to adopt a new nightly routine involving unfamiliar equipment, physical discomfort, and a learning curve, all within a compressed timeline that determines insurance coverage. That’s a significant behavioral ask, and even minor friction points (mask discomfort, dry mouth, pressure intolerance) are enough to derail the process entirely.
Two factors compound the challenge:
The 90-day cliff. Payer compliance requirements create a high-stakes window where failure has lasting consequences. Patients who miss the threshold often lose coverage, which makes subsequent adherence even harder to achieve.
Clinical bandwidth limitations. Most care teams don’t have capacity for the kind of proactive, high-frequency outreach that early-phase PAP therapy requires. By the time a patient calls with a problem, if they call at all, the pattern of non-use may already be established.
Patients don’t just need equipment. They need a support structure that catches problems early, reinforces positive behavior, and keeps therapy on track during the critical adaptation period.
How SleepWELL™ Serves as an Extension of Your Care Team
SleepWELL™ operates on a straightforward premise: patients do better when therapy is actively managed, especially during the first 90 days when drop-off risk peaks.
The program addresses common failure points through a combination of monitoring, outreach, and clinical-grade support, an approach aligned with what adherence research consistently identifies as effective.
1. Monitoring That Enables Intervention
SleepWELL™ tracks usage data and generates compliance reports that include metrics like usage time, mask leak rates, and estimated AHI. This isn’t passive data collection, rather it’s designed to support a “manage by exception” model where concerning patterns trigger follow-up before they become therapy abandonment.
Remote monitoring frameworks are specifically cited in the literature as opportunities to improve real-world adherence, particularly when paired with behavioral support rather than surveillance alone.
2. Early-Phase Outreach When It Matters Most
One of the most consistent findings in adherence research: early experience shapes long-term behavior. Patients who struggle in the first few weeks are far more likely to abandon therapy entirely.
SleepWELL™ emphasizes proactive patient contact during the initial 90-day period, supported by real-time compliance measurement. This aligns with evidence showing that coaching and telemonitoring programs improve adherence, and that longer-duration support sustains improvements more effectively than brief interventions.
The goal is to catch small problems (mask fit issues, pressure discomfort, usage gaps) before they calcify into reasons to quit.
3. Clinical-Grade Support for a Complex Therapy
PAP adherence barriers are rarely one-dimensional. Patients often need both technical troubleshooting (equipment adjustments, interface changes) and motivational reinforcement (encouragement, problem-solving, realistic expectations) to persist through the adjustment period.
SleepWELL™ provides access to trained CPAP specialists and respiratory therapists, not just customer service representatives, who can address the clinical nuances of PAP therapy. That distinction matters when the conversation moves beyond “how do I turn this on” to “why does this feel wrong and should I keep trying.”
4. Resupply and Ongoing Follow-Up
PAP therapy isn’t a one-time setup. Mask cushions degrade, filters need replacement, fit changes over time, and life circumstances shift. Without ongoing attention, even initially adherent patients can drift into non-use.
SleepWELL™ includes structured resupply and continued follow-up designed to maintain compliance and support infection control, keeping therapy functional over the long term, not just through the initial compliance window.
What the Evidence Actually Supports
The adherence literature points consistently toward several principles:
- Early intervention matters. Patients who receive intensive support in the first weeks of therapy show better long-term adherence than those who receive standard care.1
- Monitoring alone isn’t enough. Data collection without response doesn’t move the needle. The value is in actionable monitoring — identifying problems and intervening promptly.
- Behavioral support complements technical support. Adherence is a behavior change challenge, not just an equipment challenge. Programs that address motivation, troubleshooting, and reinforcement outperform those focused solely on device delivery.
- Sustained support outperforms brief interventions. Short-term coaching programs produce short-term improvements. Durable adherence requires durable support structures.
SleepWELL™ was designed with these principles in mind, not as an equipment delivery service, but as a managed program that bridges the gap between prescription and sustained use.
A Practical Consideration for Referral Partners
For clinicians and care teams managing sleep apnea populations, the question isn’t whether adherence matters — it obviously does. The question is whether your current model addresses the behavioral and operational barriers that drive non-adherence.
If your patients are receiving equipment without structured follow-up, without proactive monitoring, without early-phase intervention, then the adherence gap is built into the process.
SleepWELL™ offers an alternative: a program designed to support patients through the highest-risk period, generate compliance data your team can act on, and function as a genuine extension of clinical care rather than a transactional equipment handoff.
To learn more about SleepWELL™ and how it supports PAP therapy outcomes, contact Rotech Healthcare.
Frequently Asked Questions: CPAP Adherence and SleepWELL™
What is considered CPAP adherence or compliance?
The most commonly used definition, particularly for insurance purposes, is the CMS standard: using CPAP for at least 4 hours per night on 70% of nights during the first 90 days of therapy. However, clinical benefit typically requires more consistent use; many guidelines recommend 6+ hours nightly for optimal outcomes. SleepWELL™ tracks usage data and supports patients in meeting both payer requirements and clinical goals.
Why do so many patients stop using CPAP?
Non-adherence is multifactorial. Common reasons include mask discomfort, pressure intolerance, nasal congestion or dryness, difficulty adjusting to the sensation of positive airway pressure, and lack of perceived benefit in the early weeks. The 90-day compliance window compounds these challenges by creating a high-stakes timeline that doesn’t align well with typical behavior change patterns.
Does remote monitoring improve CPAP adherence?
Evidence suggests that remote monitoring can improve adherence, but primarily when combined with active intervention rather than passive data collection. Programs that use monitoring data to trigger outreach and troubleshooting show better outcomes than those that simply track usage without response. SleepWELL™ is designed around this “monitor and respond” model.
What makes early-phase support so important for PAP therapy?
Research consistently shows that early experience with CPAP predicts long-term adherence.1 Patients who struggle in the first few weeks are significantly more likely to abandon therapy. Early-phase support, such as proactive check-ins, rapid troubleshooting, motivational reinforcement, addresses problems before they become entrenched patterns of non-use.
How does SleepWELL™ differ from standard equipment delivery?
Standard delivery models focus on getting devices to patients. SleepWELL™ is a managed program that includes proactive monitoring, compliance reporting, early-phase outreach, access to trained CPAP specialists and respiratory therapists, and ongoing resupply coordination. The program functions as an extension of clinical care teams rather than a transactional supplier relationship.
Can SleepWELL™ generate compliance reports for clinical teams?
Yes. SleepWELL™ provides compliance reports with metrics including usage time, mask leak data, and estimated AHI. These reports can support clinical decision-making and documentation requirements.
What types of patients benefit most from structured adherence support?
While all PAP patients benefit from support, structured programs like SleepWELL™ may be particularly valuable for patients with limited health literacy, those with complex comorbidities, patients without strong caregiver support, and those who express ambivalence or anxiety about starting therapy. These populations face higher drop-off risk and often benefit most from proactive intervention.
References
- Dielesen, J., Ledwaba-Chapman, L. J., Kasetti, P., Husain, N. F., Skinner, T. C., Pengo, M. F., Whiteman, T., Asimakopoulou, K., Merritt, S., Jones, D., Dickel, P., Pulakal, S., Ward, N. R., Pepperell, J., Steier, J., & Sathyapala, S. A. (2025). Six early CPAP-usage behavioural patterns determine peak CPAP adherence and permit tailored intervention, in patients with obstructive sleep apnoea. Thorax, 80(5), thorax-2024-221763. https://doi.org/10.1136/thorax-2024-221763